Issue navigation
Volume 37, Issue Supplement_2, January 2022
CONNECTing the kidney to brain dysfunction: from animal models to clinical practice
Sponsored by COST Action CA19127-Cognitive Decline in Nephro-Neurology : European Cooperative Target (CONNECT)
EDITORIAL
Present and future of CONNECT: a new and compelling project of modern medicine
Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_2, January 2022, Pages ii1–ii3, https://doi.org/10.1093/ndt/gfab301
REVIEWS
Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease
Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_2, January 2022, Pages ii4–ii12, https://doi.org/10.1093/ndt/gfab216
Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges
Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_2, January 2022, Pages ii14–ii23, https://doi.org/10.1093/ndt/gfab284
Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment
Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_2, January 2022, Pages ii23–ii32, https://doi.org/10.1093/ndt/gfab262
Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_2, January 2022, Pages ii33–ii44, https://doi.org/10.1093/ndt/gfab223
Brain dysfunction in tubular and tubulointerstitial kidney diseases
Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_2, January 2022, Pages ii46–ii55, https://doi.org/10.1093/ndt/gfab276
Albuminuria as a risk factor for mild cognitive impairment and dementia—what is the evidence?
Nephrology Dialysis Transplantation, Volume 37, Issue Supplement_2, January 2022, Pages ii55–ii62, https://doi.org/10.1093/ndt/gfab261
